12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SCYX-7158: Phase I started

Anacor said the Drugs for Neglected Diseases initiative (Geneva, Switzerland) began a double-blind, placebo-controlled, French Phase I trial to evaluate single and multiple ascending-doses of oral SCYX-7158 in...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >